Procaps Group S.A. (PROCF)
Market Open
11 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
698.17K Market Cap
8.23 P/E Ratio
- Div Yield
17 Volume
0.15 Eps
$ 0
Previous Close Want to track PROCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PROCF trading today higher at $0, an increase of 0% from yesterday's close, completing a monthly decrease of -98.8048% or -$0.02. Over the past 12 months, PROCF stock lost -98.8048%.
PROCF is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
PROCF Chart
Procaps Group S.A. (PROCF) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
Procaps Group S.A. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is PROCF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 698.17K.
Has Procaps Group S.A. ever had a stock split?
No, there has never been a stock split.
Procaps Group S.A. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Melissa Angelini CEO | OTC PINK Exchange | 237649125 CUSIP |
| LU Country | 4,498 Employees | - Last Dividend | - Last Split | 30 Sep 2021 IPO Date |
Overview
Procaps Group S.A. is a global pharmaceutical company established in 1977 and headquartered in Luxembourg, Luxembourg. This organization is dedicated to the development, production, and marketing of pharmaceutical solutions across the world. Procaps Group serves a diverse range of healthcare needs through its comprehensive offerings, which include branded prescription drugs across multiple therapeutic areas, hospital drugs, over-the-counter (OTC) consumer healthcare products, and contract drug development and manufacturing services. Leveraging advanced soft gelatin capsule technologies amongst others, Procaps Group caters to a wide patient and consumer demographic, aiming to deliver innovative and effective healthcare solutions.
Products and Services
- Branded Prescription Drugs: These include medications in various therapeutic areas such as feminine care, pain relief, skin care, digestive health, cardiology, vision care, central nervous system, and respiratory health.
- Hospital Drugs: Catering to the needs of the healthcare institutions, the company offers a range of drugs for inpatient care including antibiotics, analgesics, blood clots, personal protective equipment, immunosuppressants, oncology, and more.
- Over-the-Counter Consumer Healthcare Products: Procaps Group provides a wide array of OTC products covering gastric intestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, supplements, and more. These products target approximately eight different therapeutic areas and aim to meet common health needs of consumers without the need for a prescription.
- Diabetes Solutions: Offering comprehensive care for diabetes, Procaps Group supplies blood glucose meters, telemonitoring for diabetes management, oral anti-diabetics, cosmeceuticals, insulin delivery systems, and more. These products aim at simplifying diabetes management for patients.
- Contract Drug Development and Manufacturing Services: The company extends its expertise to other pharmaceutical companies by providing contract services that specialize in drug development and manufacturing, especially focusing on soft gelatin capsule technologies. This service allows other companies to leverage Procaps Group’s manufacturing capabilities and expertise for their drug production needs.
Contact Information
Address: 9 Rue de Bitbourg
Phone: 356 7995 6138
Website: https://www.sofgenpharma.com
